31 West 52nd Street,16th Floor
New York , NY, 10019
New York , NY, 10019
Summary
The fund seeks to replicate the total return performance of the benchmark index, before fees and expenses, by investing in companies in the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
Next, the research team invests significantly in the component securities of More
Webiste
Directors
Jan 16, 2024- Robert S. Tull, Jr.
- William J. Smalley
- Myles J. Edwards
- James A. Simpson
Chief Compliance Officer
- Timothy Branigan
Price
- $ 25.26 ( +1.25 )
-
Jun 28, 2024Last Close
- Net Assets
-
$10.1M
Mar 28, 2024
- 52-Week High/Low
- $28.1 - $24.6
- Expense Ratio
- -
Performance
YTD
0%
3 Year
-50.2%
5 Year
-10.71%
Best
63.71%
2019
Worst
-48.54%
2008
Company Name |
Holding |
DREYFUS GOVERNMENT CASH MANAGE | 7.58 % |
Morphic Holding Inc | 1.6 % |
Longboard Pharmaceuticals Inc | 1.31 % |
uniQure NV | 1.14 % |
ORIC Pharmaceuticals Inc | 1.14 % |
Erasca Inc | 1.13 % |
Praxis Precision Medicines Inc | 1.13 % |
AnaptysBio Inc | 1.13 % |
IGM Biosciences Inc | 1.1 % |
ACELYRIN Inc | 1.08 % |
More | 1.08 % |
Documents
NAV
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
BBC | 0% | 8.9% | -2.2% | -35.1% | -22.3% | 30.4% | 63.7% | -18.3% | 56.1% | -36.6% | |
S&P 500 | -13.7% | 23.3% | 24.2% | -19.4% | 27.3% | 16.2% | 28.9% | -6.2% | 19.4% | 9.5% |
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
q1 | 0% | 19.1% | -12.3% | -27.5% | 3.6% | -23% | 22.6% | 15.3% | 26% | -34.4% | ||||
q2 | 0% | -4% | 9.3% | -22.7% | -2.8% | 47.4% | -0.6% | 6.6% | 3.6% | -5.5% | ||||
q3 | 0% | 0% | -18.1% | 13.8% | -8.5% | -9.8% | -18.3% | 4% | 21.4% | 25.8% | ||||
q4 | 0% | 0% | 29.8% | 1.7% | -15.7% | 27.2% | 59.7% | -31.2% | -3.3% | -18.7% |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025 | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
2024 | 3.8% | 18.5% | -3.1% | -10.4% | -1.1% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |